Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group

Abstract
OBJECTIVE: This multicenter, double-blind, placebo-controlled study evaluated the efficacy and safety of three doses of sertindole (12, 20, and 24 mg/day) and haloperidol (4, 8, and 16 mg/day) in t...